R M Radke1, G-P Diller1, M Duck1, S Orwat1, D Hartmann2, T Thum3, H Baumgartner1. 1. Division of Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Muenster, Germany. 2. Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany. 3. Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany Centre for Clinical and Basic Research, IRCCS San Raffaele, Rome, Italy.
Abstract
OBJECTIVE: Previous studies have suggested endothelial dysfunction in adult patients after repair of aortic coarctation (CoA). It has been proposed to play a key role in the pathogenesis of arterial hypertension in the absence of re-coarctation. We aimed to assess the presence of endothelial dysfunction, the number of endothelial progenitor cells (EPC), and the levels of proinflammatory cytokines associated with endothelial injury in contemporary patients after CoA repair. METHODS: For this prospective observational study, 20 CoA patients and 22 healthy controls were recruited. Digital reactive hyperaemia was measured by peripheral arterial tonometry. Flow cytometry was used to quantify EPCs, and a comprehensive panel of laboratory markers of endothelial dysfunction was measured. RESULTS: Half the patients had known arterial hypertension requiring medical treatment. Indices of reactive hyperaemia showed no significant difference between CoA patients (1.96±0.32) and controlss (1.765±0.48) (p=0.82). Circulating EPCs, defined by the number of CD34(+), CD34(+)/KDR(+), CD34(+)/AC133(+), CD34(+)/AC133(+)/KDR(+) or CD34(+)/CD45(-) labelled cells were equally not significantly different between the groups. Furthermore, plasma levels of inflammatory mediators and markers of endothelial function (IL-6, IL-8, ICAM1 and VCAM1) were not significantly different between the groups, as were vascular endothelial growth factor levels (p>0.05, for all). CONCLUSIONS: By contrast with earlier reports, no clinically significant difference in endothelial function between adult patients with coarctation repair and healthy controls could be demonstrated. Therefore, endothelial dysfunction may not necessarily be present in this population. Further studies are required to identify mechanisms and to develop strategies to avoid arterial hypertension in these patients. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: Previous studies have suggested endothelial dysfunction in adult patients after repair of aortic coarctation (CoA). It has been proposed to play a key role in the pathogenesis of arterial hypertension in the absence of re-coarctation. We aimed to assess the presence of endothelial dysfunction, the number of endothelial progenitor cells (EPC), and the levels of proinflammatory cytokines associated with endothelial injury in contemporary patients after CoA repair. METHODS: For this prospective observational study, 20 CoA patients and 22 healthy controls were recruited. Digital reactive hyperaemia was measured by peripheral arterial tonometry. Flow cytometry was used to quantify EPCs, and a comprehensive panel of laboratory markers of endothelial dysfunction was measured. RESULTS: Half the patients had known arterial hypertension requiring medical treatment. Indices of reactive hyperaemia showed no significant difference between CoA patients (1.96±0.32) and controlss (1.765±0.48) (p=0.82). Circulating EPCs, defined by the number of CD34(+), CD34(+)/KDR(+), CD34(+)/AC133(+), CD34(+)/AC133(+)/KDR(+) or CD34(+)/CD45(-) labelled cells were equally not significantly different between the groups. Furthermore, plasma levels of inflammatory mediators and markers of endothelial function (IL-6, IL-8, ICAM1 and VCAM1) were not significantly different between the groups, as were vascular endothelial growth factor levels (p>0.05, for all). CONCLUSIONS: By contrast with earlier reports, no clinically significant difference in endothelial function between adult patients with coarctation repair and healthy controls could be demonstrated. Therefore, endothelial dysfunction may not necessarily be present in this population. Further studies are required to identify mechanisms and to develop strategies to avoid arterial hypertension in these patients. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Constance G Weismann; Joanna Hlebowicz; Anna Åkesson; Petru Liuba; Katarina Hanseus Journal: Front Physiol Date: 2022-04-25 Impact factor: 4.755
Authors: José D Martins; Justin Zachariah; Elif Seda Selamet Tierney; Uyen Truong; Shaine A Morris; Shelby Kutty; Sarah D de Ferranti; Maria Guarino; Boban Thomas; Diana Oliveira; António Marinho; Marta António; Kimberlee Gauvreau; Nuno Jalles; Tal Geva; Miguel M Carmo; Ashwin Prakash Journal: J Am Heart Assoc Date: 2019-04-02 Impact factor: 5.501
Authors: Daniel Goeder; Renate Oberhoffer-Fritz; Leon Brudy; Laura Willinger; Michael Meyer; Peter Ewert; Jan Müller Journal: J Clin Med Date: 2022-01-19 Impact factor: 4.241
Authors: Alicia Jeanette Fischer; Christin Grundlach; Paul C Helm; Ulrike Mm Bauer; Helmut Baumgartner; Gerhard-Paul Diller Journal: Korean Circ J Date: 2021-11-05 Impact factor: 3.243